This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Management of Heart Failure in Cancer Patients and Cancer Survivors - p. 253 9. Proteasome Inhibitors as a Potential Cause of Heart Failure - p. 289 10. Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy - p. 297 11. Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction - p. 311 12. Advanced Heart Failure Therapies for Cancer Therapeutics–Related Cardiac Dysfunction - p. 327 13. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention - p. 337 14. How to Develop a Cardio-Oncology Clinic - p. 347 15. How to Develop a Cardio-oncology Fellowship - p. 361 16. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease - p. 367 17. Alternative Biomarkers for Combined Biology - p. 381 18. Cardio-oncology: The Role of Big Data - p. 403 19. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration - p. 409
No hay muestra disponible
No hay ficha técnica disponible
This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Management of Heart Failure in Cancer Patients and Cancer Survivors - p. 253 9. Proteasome Inhibitors as a Potential Cause of Heart Failure - p. 289 10. Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy - p. 297 11. Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction - p. 311 12. Advanced Heart Failure Therapies for Cancer Therapeutics–Related Cardiac Dysfunction - p. 327 13. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention - p. 337 14. How to Develop a Cardio-Oncology Clinic - p. 347 15. How to Develop a Cardio-oncology Fellowship - p. 361 16. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease - p. 367 17. Alternative Biomarkers for Combined Biology - p. 381 18. Cardio-oncology: The Role of Big Data - p. 403 19. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration - p. 409
No hay muestra disponible
No hay ficha técnica disponible
